TY - JOUR AU - Nair, H. AU - Nokes, D. J. AU - Gessner, B. D. AU - Dherani, M. AU - Madhi, S. A. AU - Singleton, R. J. PY - 2010 DA - 2010// TI - Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60206-1 DO - 10.1016/S0140-6736(10)60206-1 ID - Nair2010 ER - TY - JOUR AU - Bont, L. AU - Checchia, P. A. AU - Fauroux, B. AU - Figueras-Aloy, J. AU - Manzoni, P. AU - Paes, B. PY - 2016 DA - 2016// TI - Defining the epidemiology and burden of severe respiratory Syncytial virus infection among infants and children in western countries JO - Infect Dis Ther VL - 5 UR - https://doi.org/10.1007/s40121-016-0123-0 DO - 10.1007/s40121-016-0123-0 ID - Bont2016 ER - TY - JOUR AU - Sanchez-Luna, M. AU - Elola, F. J. AU - Fernandez-Perez, C. AU - Bernal, J. L. AU - Lopez-Pineda, A. PY - 2016 DA - 2016// TI - Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004–2012 JO - Curr Med Res Opin VL - 32 UR - https://doi.org/10.1185/03007995.2015.1136606 DO - 10.1185/03007995.2015.1136606 ID - Sanchez-Luna2016 ER - TY - JOUR AU - Pickles, R. J. AU - DeVincenzo, J. P. PY - 2015 DA - 2015// TI - Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis JO - J Pathol VL - 235 UR - https://doi.org/10.1002/path.4462 DO - 10.1002/path.4462 ID - Pickles2015 ER - TY - JOUR AU - Shay, D. K. AU - Holman, R. C. AU - Newman, R. D. AU - Liu, L. L. AU - Stout, J. W. AU - Anderson, L. J. PY - 1999 DA - 1999// TI - Bronchiolitis-associated hospitalizations among US children, 1980–1996 JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.15.1440 DO - 10.1001/jama.282.15.1440 ID - Shay1999 ER - TY - JOUR AU - Gupta, P. AU - Beam, B. W. AU - Rettiganti, M. PY - 2016 DA - 2016// TI - Temporal trends of respiratory Syncytial virus-associated hospital and ICU admissions across the United States JO - Pediatr Crit Care Med VL - 17 UR - https://doi.org/10.1097/PCC.0000000000000850 DO - 10.1097/PCC.0000000000000850 ID - Gupta2016 ER - TY - JOUR AU - Hall, C. B. AU - Weinberg, G. A. AU - Iwane, M. K. AU - Blumkin, A. K. AU - Edwards, K. M. AU - Staat, M. A. PY - 2009 DA - 2009// TI - The burden of respiratory syncytial virus infection in young children JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0804877 DO - 10.1056/NEJMoa0804877 ID - Hall2009 ER - TY - JOUR AU - Lozano, R. AU - Naghavi, M. AU - Foreman, K. AU - Lim, S. AU - Shibuya, K. AU - Aboyans, V. PY - 2012 DA - 2012// TI - Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010 JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)61728-0 DO - 10.1016/S0140-6736(12)61728-0 ID - Lozano2012 ER - TY - JOUR AU - Shi, T. AU - Balsells, E. AU - Wastnedge, E. AU - Singleton, R. AU - Rasmussen, Z. A. AU - Zar, H. J. PY - 2015 DA - 2015// TI - Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis JO - J Glob Health VL - 5 UR - https://doi.org/10.7189/jogh.05.020416 DO - 10.7189/jogh.05.020416 ID - Shi2015 ER - TY - JOUR AU - Figueras-Aloy, J. AU - Manzoni, P. AU - Paes, B. AU - Simões, E. A. AU - Bont, L. AU - Checchia, P. A. PY - 2016 DA - 2016// TI - Defining the risk and associated morbidity and mortality of severe respiratory Syncytial virus infection among preterm infants without chronic lung disease or congenital heart disease JO - Infect Dis Ther VL - 5 UR - https://doi.org/10.1007/s40121-016-0130-1 DO - 10.1007/s40121-016-0130-1 ID - Figueras-Aloy2016 ER - TY - JOUR AU - Pisesky, A. AU - Benchimol, E. I. AU - Wong, C. A. AU - Hui, C. AU - Crowe, M. AU - Belair, M. A. PY - 2016 DA - 2016// TI - Incidence of hospitalization for respiratory Syncytial virus infection amongst children in Ontario, Canada: a population-based study using validated health administrative data JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0150416 DO - 10.1371/journal.pone.0150416 ID - Pisesky2016 ER - TY - JOUR AU - Al-Shawwa, B. AU - Al-Huniti, N. AU - Abu-Hasan, M. PY - 2006 DA - 2006// TI - Respiratory Syncytial virus Bronchiolitis and risk of subsequent wheezing: a matter of severity JO - Pediatric Asthma Allergy & Immunology VL - 19 UR - https://doi.org/10.1089/pai.2006.19.26 DO - 10.1089/pai.2006.19.26 ID - Al-Shawwa2006 ER - TY - JOUR AU - Figueras-Aloy, J. AU - Carbonell-Estrany, X. AU - Quero, J. PY - 2004 DA - 2004// TI - Case–control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain JO - Pediatr Infect Dis J VL - 23 UR - https://doi.org/10.1097/01.inf.0000136869.21397.6b DO - 10.1097/01.inf.0000136869.21397.6b ID - Figueras-Aloy2004 ER - TY - JOUR AU - Figueras-Aloy, J. AU - Carbonell-Estrany, X. AU - Quero-Jiménez, J. AU - Fernández-Colomer, B. AU - Guzmán-Cabañas, J. AU - Echaniz-Urcelay, I. PY - 2008 DA - 2008// TI - FLIP-2 study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks JO - Pediatr Infect Dis J VL - 27 UR - https://doi.org/10.1097/INF.0b013e3181710990 DO - 10.1097/INF.0b013e3181710990 ID - Figueras-Aloy2008 ER - TY - JOUR AU - Carbonell-Estrany, X. AU - Pérez-Yarza, E. G. AU - García, L. S. AU - Guzmán Cabañas, J. M. AU - Bòria, E. V. AU - Atienza, B. B. PY - 2015 DA - 2015// TI - Long-term burden and respiratory effects of respiratory Syncytial virus hospitalization in preterm infants-the SPRING study JO - PLoS One VL - 8 ID - Carbonell-Estrany2015 ER - TY - STD TI - The European Medicines Agency Synagis summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000257/WC500056908.pdf. Accesed 4 Nov 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000257/WC500056908.pdf ID - ref16 ER - TY - JOUR AU - Blanken, M. O. AU - Rovers, M. M. AU - Molenaar, J. M. AU - Winkler-Seinstra, P. L. AU - Meijer, A. AU - Kimpen, J. L. PY - 2013 DA - 2013// TI - Respiratory syncytial virus and recurrent wheeze in healthy preterm infants JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1211917 DO - 10.1056/NEJMoa1211917 ID - Blanken2013 ER - TY - JOUR AU - Simoes, E. A. AU - Groothuis, J. R. AU - Carbonell-Estrany, X. AU - Rieger, C. H. AU - Mitchell, I. AU - Fredrick, L. M. PY - 2007 DA - 2007// TI - Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing JO - J Pediatr VL - 151 UR - https://doi.org/10.1016/j.jpeds.2007.02.032 DO - 10.1016/j.jpeds.2007.02.032 ID - Simoes2007 ER - TY - JOUR AU - Yoshihara, S. AU - Kusuda, S. AU - Mochizuki, H. AU - Okada, K. AU - Nishima, S. AU - Simões, E. A. PY - 2013 DA - 2013// TI - Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants JO - Pediatrics VL - 132 UR - https://doi.org/10.1542/peds.2013-0982 DO - 10.1542/peds.2013-0982 ID - Yoshihara2013 ER - TY - JOUR AU - Resch, B. AU - Sommer, C. AU - Nuijten, M. J. AU - Seidinger, S. AU - Walter, E. AU - Schoellbauer, V. PY - 2012 DA - 2012// TI - Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria JO - Pediatr Infect Dis J VL - 31 UR - https://doi.org/10.1097/INF.0b013e318235455b DO - 10.1097/INF.0b013e318235455b ID - Resch2012 ER - TY - JOUR AU - Nuijten, M. AU - Lebmeier, M. AU - Wittenberg, W. PY - 2009 DA - 2009// TI - Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands JO - J Med Econ VL - 12 UR - https://doi.org/10.3111/13696990903316961 DO - 10.3111/13696990903316961 ID - Nuijten2009 ER - TY - JOUR AU - Neovius, K. AU - Buesch, K. AU - Sandström, K. AU - Neovius, M. PY - 2011 DA - 2011// TI - Cost-effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden JO - Acta Paediatr VL - 100 UR - https://doi.org/10.1111/j.1651-2227.2011.02309.x DO - 10.1111/j.1651-2227.2011.02309.x ID - Neovius2011 ER - TY - JOUR AU - Nuijten, M. J. AU - Wittenberg, W. AU - Lebmeier, M. PY - 2007 DA - 2007// TI - Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis JO - PharmacoEconomics VL - 25 UR - https://doi.org/10.2165/00019053-200725010-00006 DO - 10.2165/00019053-200725010-00006 ID - Nuijten2007 ER - TY - JOUR AU - Bentley, A. AU - Filipovic, I. AU - Gooch, K. AU - Büsch, K. PY - 2013 DA - 2013// TI - A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom JO - Health Econ Rev VL - 3 UR - https://doi.org/10.1186/2191-1991-3-18 DO - 10.1186/2191-1991-3-18 ID - Bentley2013 ER - TY - JOUR AU - Mahadevia, P. J. AU - Masaquel, A. S. AU - Polak, M. J. AU - Weiner, L. B. PY - 2012 DA - 2012// TI - Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective JO - J Med Econ VL - 15 UR - https://doi.org/10.3111/13696998.2012.690013 DO - 10.3111/13696998.2012.690013 ID - Mahadevia2012 ER - TY - JOUR AU - Weiner, L. B. AU - Masaquel, A. S. AU - Polak, M. J. AU - Mahadevia, P. J. PY - 2012 DA - 2012// TI - Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States JO - J Med Econ VL - 15 UR - https://doi.org/10.3111/13696998.2012.672942 DO - 10.3111/13696998.2012.672942 ID - Weiner2012 ER - TY - JOUR AU - Elhassan, N. O. AU - Sorbero, M. E. AU - Hall, C. B. AU - Stevens, T. P. AU - Dick, A. W. PY - 2006 DA - 2006// TI - Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease JO - Arch Pediatr Adolesc Med VL - 160 UR - https://doi.org/10.1001/archpedi.160.10.1070 DO - 10.1001/archpedi.160.10.1070 ID - Elhassan2006 ER - TY - JOUR AU - Lázaro y de Mercado, P. AU - Figueras Aloy, J. AU - Doménech Martínez, E. AU - Echániz Urcelay, I. AU - Closa Monasterolo, R. AU - Wood, M. A. PY - 2006 DA - 2006// TI - La eficiencia (coste-efectividad) de palivizumab como profilaxis para la infección por virus respiratorio sincitial en prematuros de 32–35 semanas en España JO - An Pediatr VL - 65 UR - https://doi.org/10.1157/13092505 DO - 10.1157/13092505 ID - Lázaro y de Mercado2006 ER - TY - JOUR AU - Nuijten, M. J. AU - Wittenberg, W. PY - 2010 DA - 2010// TI - Cost effectiveness of palivizumab in Spain: an analysis using observational data JO - Eur J Health Econ VL - 11 UR - https://doi.org/10.1007/s10198-009-0206-x DO - 10.1007/s10198-009-0206-x ID - Nuijten2010 ER - TY - STD TI - Agencia de Evaluación de Tecnología Sanitaria de. Efectividad, seguridad y eficiencia de palivizumab en la prevención de la infección por el virus respiratorio sincitial en prematuros. Technical Report 2014. Seville. http://www.aetsa.org/publicacion/efectividad-seguridad-y-eficiencia-del-palivizumab-en-la-prevencion-de-la-infeccion-por-el-virus-respiratorio-sincitial-en-prematuros. Accessed 01 Nov 2016. UR - http://www.aetsa.org/publicacion/efectividad-seguridad-y-eficiencia-del-palivizumab-en-la-prevencion-de-la-infeccion-por-el-virus-respiratorio-sincitial-en-prematuros ID - ref30 ER - TY - BOOK AU - Drummonds, M. AU - Sculpher, M. PY - 2005 DA - 2005// TI - Methods for the economic evaluation of health care Programmes PB - Oxford University Press CY - Oxford ID - Drummonds2005 ER - TY - JOUR AU - López Bastida, J. AU - Oliva, J. AU - Antoñanzas, F. AU - García-Altés, A. AU - Gisbert, R. AU - Mar, J. PY - 2010 DA - 2010// TI - Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias JO - Gac Sanit VL - 24 UR - https://doi.org/10.1016/j.gaceta.2009.07.011 DO - 10.1016/j.gaceta.2009.07.011 ID - López Bastida2010 ER - TY - JOUR AU - Figueras-Aloy, J. AU - Carbonell-Estrany, X. AU - Quero-Jiménez, J. AU - Fernández-Colomer, B. AU - Guzmán-Cabañas, J. AU - Echaniz-Urcelay, I. PY - 2010 DA - 2010// TI - Efectividad del palivizumab en la prevención de la infección por virus respiratorio sincitial en prematuros de 32.1 a 35.0 semanas de gestación en España JO - Acta Pediatr Esp VL - 68 ID - Figueras-Aloy2010 ER - TY - STD TI - General Council of Official Pharmaceutical Collegues Bot Plus 2.0. Available at URL: https://botplusweb.portalfarma.com/. Accessed 4 Nov 2016. UR - https://botplusweb.portalfarma.com/ ID - ref34 ER - TY - STD TI - Royal Decree-Law 8–2010. Real Decreto-ley 8/2010, de 20 de mayo, por el que se adoptan medidas extraordinarias para la reducción del déficit público. http://www.boe.es/boe/dias/2010/05/24/pdfs/BOE-A-2010-8228.pdf; Accessed 4 Nov 2016. UR - http://www.boe.es/boe/dias/2010/05/24/pdfs/BOE-A-2010-8228.pdf ID - ref35 ER - TY - STD TI - Consulting O. Base de datos de costes sanitarios eSalud. Barcelona: Oblikue Consulting; 2016. http://esalud.oblikue.com/. Accessed 11 Feb 2016. UR - http://esalud.oblikue.com/ ID - ref36 ER - TY - JOUR AU - Blasco Bravo, A. J. AU - Pérez-Yarza, E. G. AU - Lázaro y de Mercado, P. AU - Bonillo Perales, A. AU - Díaz Vazquez, C. A. AU - Moreno Galdó, A. PY - 2011 DA - 2011// TI - Coste del asma en pediatría en España: un modelo de evaluación de costes basado en la prevalencia JO - An Pediatr (Barc) VL - 74 UR - https://doi.org/10.1016/j.anpedi.2010.10.006 DO - 10.1016/j.anpedi.2010.10.006 ID - Blasco Bravo2011 ER - TY - JOUR AU - Greenough, A. AU - Alexander, J. AU - Burgess, S. AU - Bytham, J. AU - Chetcuti, P. A. AU - Hagan, J. PY - 2004 DA - 2004// TI - Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection JO - Arch Dis Child VL - 89 UR - https://doi.org/10.1136/adc.2003.036129 DO - 10.1136/adc.2003.036129 ID - Greenough2004 ER - TY - JOUR AU - Chiou, C. F. AU - Weaver, M. R. AU - Bell, M. A. AU - Lee, T. A. AU - JWl, K. PY - 2005 DA - 2005// TI - Development of the multi-attribute pediatric asthma health outcome measure (PAHOM) JO - Int J Qual Health Care VL - 17 UR - https://doi.org/10.1093/intqhc/mzh086 DO - 10.1093/intqhc/mzh086 ID - Chiou2005 ER - TY - JOUR AU - Checchia, P. A. AU - Nalysnyk, L. AU - Fernandes, A. W. AU - Mahadevia, P. J. AU - Xu, Y. AU - Fahrbach, K. PY - 2011 DA - 2011// TI - Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis JO - Pediatr Crit Care Med VL - 12 UR - https://doi.org/10.1097/PCC.0b013e3182070990 DO - 10.1097/PCC.0b013e3182070990 ID - Checchia2011 ER - TY - JOUR AU - Catalá López, F. AU - García-Altés, A. PY - 2008 DA - 2008// TI - Algunas consideraciones metodológicas en la evaluación económica de intervenciones preventivas: un debate abierto JO - PharmacoEconomics Span Res Art VL - 5 UR - https://doi.org/10.1007/BF03320838 DO - 10.1007/BF03320838 ID - Catalá López2008 ER - TY - JOUR AU - Sacristán, J. A. AU - Oliva, J. AU - Del Llano, J. AU - Prieto, L. AU - Pinto, J. L. PY - 2002 DA - 2002// TI - ¿Qué es una tecnología sanitaria eficiente en España? JO - Gac Sanit VL - 16 UR - https://doi.org/10.1016/S0213-9111(02)71933-X DO - 10.1016/S0213-9111(02)71933-X ID - Sacristán2002 ER - TY - STD TI - Vallejo-Torres L, García-Lorenzo B, Castilla I, Valcárcel Nazco C, García-Pérez L, Linertová R, Serrano-Aguilar P. Valor Monetario de un Año de Vida Ajustado por Calidad: Estimación empírica del coste de oportunidad en el Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud: Informes de Evaluación de Tecnologías Sanitarias; 2015. http://www3.gobiernodecanarias.org/sanidad/scs/contenidoGenerico.jsp?idDocument=e690e0c1-cbed-11e5-a9c5-a398589805dc&idCarpeta=ce590e62-7af0-11e4-a62a-758e414b4260. Accessed 10 Jan 2017 UR - http://www3.gobiernodecanarias.org/sanidad/scs/contenidoGenerico.jsp?idDocument=e690e0c1-cbed-11e5-a9c5-a398589805dc&idCarpeta=ce590e62-7af0-11e4-a62a-758e414b4260 ID - ref43 ER - TY - STD TI - Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV study group. Pediatrics. 1998;102(3 Pt 1):531–7. ID - ref44 ER - TY - JOUR AU - Sampalis, J. S. PY - 2003 DA - 2003// TI - Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants JO - J Pediatr VL - 143 UR - https://doi.org/10.1067/S0022-3476(03)00513-4 DO - 10.1067/S0022-3476(03)00513-4 ID - Sampalis2003 ER - TY - JOUR AU - Rodríguez Barrios, J. M. AU - Pérez Alcántara, F. AU - Crespo Palomo, C. AU - González García, P. AU - Antón De Las Heras, E. AU - Brosa Riestra, M. PY - 2012 DA - 2012// TI - The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications JO - Eur J Health Econ VL - 13 UR - https://doi.org/10.1007/s10198-011-0326-y DO - 10.1007/s10198-011-0326-y ID - Rodríguez Barrios2012 ER - TY - JOUR PY - 2014 DA - 2014// TI - Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection JO - Pediatrics VL - 134 UR - https://doi.org/10.1542/peds.2014-1666 DO - 10.1542/peds.2014-1666 ID - ref47 ER - TY - JOUR AU - Figueras Aloy, J. AU - Carbonell Estrany, X. PY - 2015 DA - 2015// TI - Update of recommendations on the use of palivizumab as prophylaxis in RSV infections JO - An Pediatr VL - 82 UR - https://doi.org/10.1016/j.anpedi.2014.10.016 DO - 10.1016/j.anpedi.2014.10.016 ID - Figueras Aloy2015 ER - TY - JOUR AU - Yogev, R. AU - Krilov, L. R. AU - Fergie, J. E. AU - Weiner, L. B. PY - 2015 DA - 2015// TI - Re-evaluating the new committee on infectious diseases recommendations for Palivizumab use in premature infants JO - Pediatr Infect Dis J VL - 34 UR - https://doi.org/10.1097/INF.0000000000000808 DO - 10.1097/INF.0000000000000808 ID - Yogev2015 ER -